Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 31-37 of 37
Item hits:
Issue DateTitleAuthor(s)
16-Mar-2017Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-gamma (PPAR gamma) are disrupted by retinal disease-associated mutationsFulton, J; Mazumder, B; Whitchurch, JB; Monteiro, CJ; Collins, HM, et al
23-Nov-2017The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation.Smith, L; Farzan, R; Ali, S; Buluwela, L; Saurin, AT, et al
5-Jan-2018Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerAsaduzzaman, M; Constantinou, S; Min, H; Gallon, J; Lin, M-L, et al
26-May-2017Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ER alpha metastatic breast cancerMagnani, L; Frige, G; Gadaleta, RM; Corleone, G; Fabris, S, et al
1-May-2019Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESSzijgyarto, Z; Flach, KD; Opdam, M; Palmieri, C; Linn, SC, et al
6-Aug-2019Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionNguyen, VTM; Barozzi, I; Faronato, M; Lombardo, Y; Steel, JH, et al
17-Sep-2019ABC transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942.Sava, G; Fan, H; Fisher, R; Coombes, R; Buluwela, L, et al